참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Sodium Hydroxide | HCID 14798 | — |
| 반응물 | Potassium Nitrate | HCID 24434 | — |
| 반응물 | 7-Methoxy-2,3,4,5-tetrahydro-1h-3-benzazepine | HCID 13853348 | — |
| 반응물 | 1H-1-Benzazepine | HCID 15559658 | — |
| 반응물 | HCID 178514236 | HCID 178514236 | — |
| 용매 | Acetonitrile | HCID 6342 | — |
| 용매 | Trifluoroacetic anhydride | HCID 9845 | — |
| 생성물 | 7-Methoxy-9-nitro-2,3,4,5-tetrahydro-1H-benzo[d]azepine | HCID 67264226 | — |
| 생성물 | 7-Methoxy-8-nitro-2,3,4,5-tetrahydro-1H-benzo[d]azepine | HCID 67264351 | — |
반응 단계
7-Methoxy-2,3,4,5-tetrahydro-1H-benzo[d]azepine (750 mg/4.2 mmol) was dissolved in a mixture of dry acetonitrile (3 mL) and trifluoroacetic anhydride (3 mL) and cooled to 0° C. (ice bath). The trifluoroacetyl amide of the benzazepine forms immediately (observed by HPLC). Potassium nitrate (450 mg/4.2 mmol) was added in one portion and the mixture allowed to warm to room temperature. After one hour the reaction was complete (HPLC); 33% sodium hydroxide (1 mL) was added via pipette (exotherm) and the mixture stirred for an additional two hours (to hydrolyze the TFA amide). The resulting mixture was partitioned between water (20 mL) and methylene chloride (20 mL). The aqueous layer was extracted with an additional portion of methylene chloride (20 mL) and the combined organics were dried over magnesium sulfate, filtered and concentrated to afford a 1.7:1 ratio of 7-Methoxy-8-nitro-2,3,4,5-tetrahydro-1H-benzo[d]azepine and 7-Methoxy-9-nitro-2,3,4,5-tetrahydro-1H-benzo[d]azepine as a yellow oil (770 mg/82%). The material was used without further purification. 1H NMR (400 MHz, CDCl3) major isomer: δ 7.66 (s, 1H), 6.82 (s 1H); minor isomer: 7.14 (d, J=8.3 Hz, 1H), 6.76 (d, J=8.3 Hz, 1H).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US08552186B2 |
|---|
| 출처 데이터셋 | uspto-grants-2013_10 |
|---|
| ORD ID | ord-a5235457eceb45c7b9d4ab36eea368bf |
|---|
| 출처 메모 | uspto-grants-2013_10 |
|---|